ONE-WAYOngoing theme · still written in the latest filings
Becoming a global category pharmaceutical company based on glycoscience
A long-term policy of focusing R&D on glycoscience, continuously bringing innovative pharmaceuticals to market, and establishing international competitiveness in glycoscience and a position as a global category pharmaceutical company.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.